Johnson & Johnson halts production of single-dose COVID-19 vaccine, report says
CBSN
Drugmaker Johnson & Johnson has halted production of its single-dose COVID-19 vaccine, according to a New York Times report.
The pharmaceutical company last year quietly shut down production at a plant in Leiden, Netherlands, which was the only facility where usable doses of the vaccine are manufactured, catching some of its customers off guard, the report states.
Johnson & Johnson has instead been using the plant to work on an experimental and potentially more profitable drug that could protect against an unrelated respiratory virus, according to the report.
More Related News